| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), AGEN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.97M | - | - | |
| Other | 200.0K | - | - | |
| Other | 100.0K | - | - | |
| Dir | 100.0K | - | - | |
| Dir | 52.0K | $358.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2016 | Armen Garo H49 | Chairman &CEO | Buy | 100,000 | $3.18 | $317,895.00 | +7.7% | |
| May 5, 2016 | Baysal Ozer | Chief Business Officer | Buy | 2,250 | $3.10 | $6,974.78 | +7.2% | |
| Mar 7, 2016 | Armen Garo H49 | Chairman &CEO | Buy | 200,000 | $4.03 | $805,600.00 | +19.0% | |
| Dec 29, 2015 | Armen Garo H49 | Chairman &CEO | Sell | 219,576 | $4.59 | $1,007,877.33 | -15.3% | |
| Sep 25, 2015 | Armen Garo H49 | Chairman &CEO | Buy | 100,000 | $5.03 | $503,000.00 | +7.6% | |
| Sep 25, 2015 | Ballantyne Charles Evan | Chief Financial Officer | Buy | 10,000 | $5.05 | $50,500.00 | New | |
| Jan 9, 2015 | Qvt Associates GP LLC | 10% Owner | Sell | 2,343,630 | $5.31 | $12,451,321.74 | -25.3% |